GlaxoSmithKline Gets Expanded FDA Win for Fluarix
Glaxo announced today it has received approval from the FDA’s Center for Biologics Evaluation and Research expanding the indication for FLUARIX to include use in persons 6 months and older.
Source: BioSpace